1. |
Ball J, Carrington MJ, McMurray JJ, et al. Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century. Int J Cardiol, 2013, 167(5): 1807-1824.
|
2. |
Lloyd-Jones DM, Wang TJ, Leip EP, et al. Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation, 2004, 110(9): 1042-1046.
|
3. |
Lee HY, Yang PS, Kim TH, et al. Atrial fibrillation and the risk of myocardial infarction: a nation-wide propensity-matched study. Sci Rep, 2017, 7(1): 12716.
|
4. |
Conen D, Chae CU, Glynn RJ, et al. Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation. JAMA, 2011, 305(20): 2080-2087.
|
5. |
Chen LY, Sotoodehnia N, Bůžková P, et al. Atrial fibrillation and the risk of sudden cardiac death: the atherosclerosis risk in communities study and cardiovascular health study. JAMA Intern Med, 2013, 173(1): 29-35.
|
6. |
Kalantarian S, Ay H, Gollub RL, et al. Association between atrial fibrillation and silent cerebral infarctions: a systematic review and meta-analysis. Ann Intern Med, 2014, 161(9): 650-658.
|
7. |
Benjamin EJ, Levy D, Vaziri SM, et al. Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA, 1994, 271(11): 840-844.
|
8. |
Zacharias A, Schwann TA, Riordan CJ, et al. Obesity and risk of new-onset atrial fibrillation after cardiac surgery. Circulation, 2005, 112(21): 3247-3255.
|
9. |
Ahmari SA, Bunch TJ, Chandra A, et al. Prevalence, pathophysiology, and clinical significance of post-heart transplant atrial fibrillation and atrial flutter. J Heart Lung Transplant, 2006, 25(1): 53-60.
|
10. |
Pathak RK, Middeldorp ME, Lau DH, et al. Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study. J Am Coll Cardiol, 2014, 64(21): 2222-2231.
|
11. |
Martínez-González MÁ, Toledo E, Arós F, et al. Extravirgin olive oil consumption reduces risk of atrial fibrillation: the PREDIMED (Prevención con Dieta Mediterránea) trial. Circulation, 2014, 130(1): 18-26.
|
12. |
Abed HS, Wittert GA, Leong DP, et al. Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial. JAMA, 2013, 310(19): 2050-2060.
|
13. |
N J, Francis J. Atrial fibrillation and hyperthyroidism. Indian Pacing Electrophysiol J, 2005, 5(4): 305-311.
|
14. |
Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab, 2002, 87(2): 489-499.
|
15. |
Collet TH, Gussekloo J, Bauer DC, et al. Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med, 2012, 172(10): 799-809.
|
16. |
Sun J, Yao L, Fang Y, et al. Relationship between subclinical thyroid dysfunction and the risk of cardiovascular outcomes: a systematic review and meta-analysis of prospective cohort studies. Int J Endocrinol, 2017, 2017: 8130796.
|
17. |
Nanchen D, Gussekloo J, Westendorp RG, et al. Subclinical thyroid dysfunction and the risk of heart failure in older persons at high cardiovascular risk. J Clin Endocrinol Metab, 2012, 97(3): 852-861.
|
18. |
Park YJ, Yoon JW, Kim KI, et al. Subclinical hypothyroidism might increase the risk of transient atrial fibrillation after coronary artery bypass grafting. Ann Thorac Surg, 2009, 87(6): 1846-1852.
|
19. |
Cappola AR, Fried LP, Arnold AM, et al. Thyroid status, cardiovascular risk, and mortality in older adults. JAMA, 2006, 295(9): 1033-1041.
|
20. |
Selmer C, Olesen JB, Hansen ML, et al. The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study. BMJ, 2012, 345: e7895.
|
21. |
单忠艳. 《中国甲状腺疾病诊治指南》导读. 中国实用内科杂志, 2008, 28(4): 260-261.
|
22. |
Gammage MD, Parle JV, Holder RL, et al. Association between serum free thyroxine concentration and atrial fibrillation. Arch Intern Med, 2007, 167(9): 928-934.
|
23. |
Auer J, Scheibner P, Mische T, et al. Subclinical hyperthyroidism as a risk factor for atrial fibrillation. Am Heart J, 2001, 142(5): 838-842.
|
24. |
Kong SH, Yoon JW, Kim SY, et al. Subclinical hypothyroidism and coronary revascularization after coronary artery bypass grafting. Am J Cardiol, 2018, 122(11): 1862-1870.
|
25. |
Martínez-Comendador J, Marcos-Vidal JM, Gualis J, et al. Subclinical hypothyroidism might increase the risk of postoperative atrial fibrillation after aortic valve replacement. Thorac Cardiovasc Surg, 2016, 64(5): 427-433.
|
26. |
Sawin CT, Geller A, Wolf PA, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med, 1994, 331(19): 1249-1252.
|